Health news
The use of vitamins B1, B6, B12, and B9, both alone and in combination, might be effective as an adjuvant for the treatment and prophylaxis of episodic migraine in women, according to study findings presented…
History of Present Illness A man in his late 40s comes to the emergency department with a complaint of blurry vision that lasted for approximately 20 minutes before returning to normal. The loss of focused vision…
Yoga therapy may be an effective treatment for migraine, according to study findings published in the American Journal of Emergency Medicine. Migraine, the second-leading cause of disability worldwide, can reduce an individual’s ability to study…
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for intranasal zavegepant, an investigational calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine in adults. The…
Positive results were announced from a phase 3 study evaluating atogepant, an oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the preventive treatment of chronic migraine in adults. The global, randomized, double-blind, placebo-controlled, parallel-group PROGRESS…
Dietary intake may precipitate migraine attacks, with up to 60% of patients reporting exacerbations following consumption of specific foods and beverages. Chocolate, coffee, cheese, and alcohol are among the most commonly identified migraine triggers across…
Treatment with erenumab-aooe, a calcitonin gene-related peptide (CGRP) receptor antagonist, was associated with superior efficacy and a lower discontinuation rate vs topiramate in adults with episodic or chronic migraine, according to findings from a phase…
Chronic migraine affects an estimated 1.4%-2.2% of people worldwide, with a preponderance of cases in women (1.7%-4.0%) compared to men (0.6%-0.7%). Each year, approximately 3% of individuals with episodic migraine progress to chronic migraine.1 In…
Newer migraine pharmacotherapies appear to be less effective than triptans, according to findings from a systematic review and meta-analysis published in JAMA Network Open. Newer medication classes include the 5-hydroxytryptamine1F receptor agonists (lasmiditan) and the…
Trudhesa (dihydroergotamine mesylate) nasal spray is now available for the acute treatment of migraine with or without aura in adults. Trudhesa uses proprietary technology to deliver a lower dose (0.725mg per spray) of dihydroergotamine mesylate…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021